CUSIP 230770109COMCPIXQ4 2025
19 filings · latest Feb 9, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Ikarian Capital, LLC | 555.9K | $2.21M |
| 2 | Renaissance Technologies LLC | 472.2K | $1.88M |
| 3 | Vanguard Group Inc | 411.8K | $1.64M |
| 4 | Perceptive Advisors LLC | 341.1K | $1.36M |
| 5 | Dimensional Fund Advisors LP | 272.3K | $1.08M |
| 6 | Bridgeway Capital Management, LLC | 163.5K | $650.6K |
| 7 | Boothbay Fund Management, LLC | 128.5K | $511.5K |
| 8 | Geode Capital Management, LLC | 107.3K | $427.0K |
| 9 |
| 4 | Apr 24, 2025 | Integrated Core Strategies (Us) LLC | 13G/A | 11.0% | 809.9K | SEC |
| 5 | Feb 13, 2025 | A.J. Kazimi | 13G | 40.8% | 5.70M | SEC |
| 6 | Feb 11, 2025 | Integrated Core Strategies (Us) LLC | 13G | 11.0% | 1.23M | SEC |
| 7 | Feb 9, 2024 | Cumberland Pharmaceuticals Inc | 13G | 40.1% | 5.72M | SEC |
| 8 | Feb 10, 2023 | Kazimi A J | 13G | 39.4% | 5.75M | SEC |
| 9 | Feb 14, 2022 | Kazimi A J | 13G | 38.3% | 5.77M | SEC |
| 10 | Feb 8, 2022 | Dimensional Fund Advisors LP | 13G/A | 4.4% | 652.6K | SEC |
See the full Schedule 13D/13G history for Cumberland Pharmaceuticals I.
Unlock full history| J. Goldman & Co LP |
| 94.5K |
| $376.3K |
| 10 | Bank Of New York Mellon Corp | 72.5K | $288.6K |